TY - JOUR PY - 2005 DA - 2005// TI - Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66544-0 DO - 10.1016/S0140-6736(05)66544-0 ID - ref1 ER - TY - JOUR AU - Ring, A. AU - Dowsett, M. PY - 2004 DA - 2004// TI - Mechanisms of tamoxifen resistance JO - Endocr Relat Cancer VL - 11 UR - https://doi.org/10.1677/erc.1.00776 DO - 10.1677/erc.1.00776 ID - Ring2004 ER - TY - JOUR AU - Beelen, K. AU - Zwart, W. AU - Linn, S. C. PY - 2012 DA - 2012// TI - Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? JO - Nat Rev Clin Oncol VL - 9 UR - https://doi.org/10.1038/nrclinonc.2012.121 DO - 10.1038/nrclinonc.2012.121 ID - Beelen2012 ER - TY - JOUR AU - Lim, Y. C. AU - Desta, Z. AU - Flockhart, D. A. AU - Skaar, T. C. PY - 2005 DA - 2005// TI - Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen JO - Cancer Chemother Pharmacol VL - 55 UR - https://doi.org/10.1007/s00280-004-0926-7 DO - 10.1007/s00280-004-0926-7 ID - Lim2005 ER - TY - JOUR AU - Johnson, M. D. AU - Zuo, H. AU - Lee, K. -. H. AU - Trebley, J. P. AU - Rae, J. M. AU - Weatherman, R. V. AU - Desta, Z. AU - Flockhart, D. A. AU - Skaar, T. C. PY - 2004 DA - 2004// TI - Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen JO - Breast Cancer Res Treat VL - 85 UR - https://doi.org/10.1023/B:BREA.0000025406.31193.e8 DO - 10.1023/B:BREA.0000025406.31193.e8 ID - Johnson2004 ER - TY - JOUR AU - Lu, W. J. AU - Desta, Z. AU - Flockhart, D. A. PY - 2012 DA - 2012// TI - Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer JO - Breast Cancer Res Treat VL - 131 UR - https://doi.org/10.1007/s10549-011-1428-z DO - 10.1007/s10549-011-1428-z ID - Lu2012 ER - TY - JOUR AU - Teunissen, S. F. AU - Rosing, H. AU - Seoane, M. D. AU - Brunsveld, L. AU - Schellens, J. H. M. AU - Schinkel, A. H. AU - Beijnen, J. H. PY - 2011 DA - 2011// TI - Investigational study of tamoxifen phase I metabolites using chromatographic and spectroscopic analytical techniques JO - J Pharm Biomed Anal VL - 55 UR - https://doi.org/10.1016/j.jpba.2011.02.009 DO - 10.1016/j.jpba.2011.02.009 ID - Teunissen2011 ER - TY - JOUR AU - Madlensky, L. AU - Natarajan, L. AU - Tchu, S. AU - Pu, M. AU - Mortimer, J. AU - Flatt, S. W. AU - Nikoloff, D. M. AU - Hillman, G. AU - Fontecha, M. R. AU - Lawrence, H. J. PY - 2011 DA - 2011// TI - Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes JO - Clin Pharmacol Ther VL - 89 UR - https://doi.org/10.1038/clpt.2011.32 DO - 10.1038/clpt.2011.32 ID - Madlensky2011 ER - TY - JOUR AU - Barginear, M. F. AU - Jaremko, M. AU - Peter, I. AU - Yu, C. AU - Kasai, Y. AU - Kemeny, M. AU - Raptis, G. AU - Desnick, R. J. PY - 2011 DA - 2011// TI - Increasing tamoxifen dose in breast cancer patients based on CYP2D6 genotypes and endoxifen levels: effect on active metabolite isomers and the antiestrogenic activity score JO - Clin Pharmacol Ther VL - 90 UR - https://doi.org/10.1038/clpt.2011.153 DO - 10.1038/clpt.2011.153 ID - Barginear2011 ER - TY - JOUR AU - Irvin, W. J. AU - Walko, C. M. AU - Weck, K. E. AU - Ibrahim, J. G. AU - Chiu, W. K. AU - Dees, E. C. AU - Moore, S. G. AU - Olajide, O. A. AU - Graham, M. L. AU - Canale, S. T. PY - 2011 DA - 2011// TI - Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.4427 DO - 10.1200/JCO.2010.31.4427 ID - Irvin2011 ER - TY - JOUR AU - Jin, Y. AU - Desta, Z. AU - Stearns, V. AU - Ward, B. AU - Ho, H. AU - Lee, K. -. H. AU - Skaar, T. AU - Storniolo, A. M. AU - Li, L. AU - Araba, A. PY - 2005 DA - 2005// TI - CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji005 DO - 10.1093/jnci/dji005 ID - Jin2005 ER - TY - JOUR AU - Rae, J. M. AU - Drury, S. AU - Hayes, D. F. AU - Stearns, V. AU - Thibert, J. N. AU - Haynes, B. P. AU - Salter, J. AU - Sestak, I. AU - Cuzick, J. AU - Dowsett, M. PY - 2012 DA - 2012// TI - CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients JO - J Natl Cancer Inst VL - 104 UR - https://doi.org/10.1093/jnci/djs126 DO - 10.1093/jnci/djs126 ID - Rae2012 ER - TY - JOUR AU - Regan, M. M. AU - Leyland-Jones, B. AU - Bouzyk, M. AU - Pagani, O. AU - Tang, W. AU - Kammler, R. AU - Dell’orto, P. AU - Biasi, M. O. AU - Thürlimann, B. AU - Lyng, M. B. PY - 2012 DA - 2012// TI - CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1–98 trial JO - J Natl Cancer Inst VL - 104 UR - https://doi.org/10.1093/jnci/djs125 DO - 10.1093/jnci/djs125 ID - Regan2012 ER - TY - JOUR AU - Brauch, H. AU - Schroth, W. AU - Goetz, M. P. AU - Mürdter, T. E. AU - Winter, S. AU - Ingle, J. N. AU - Schwab, M. AU - Eichelbaum, M. PY - 2012 DA - 2012// TI - Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.6625 DO - 10.1200/JCO.2012.44.6625 ID - Brauch2012 ER - TY - JOUR AU - Potthoff, K. AU - Hofheinz, R. AU - Hassel, J. C. AU - Volkenandt, M. AU - Lordick, F. AU - Hartmann, J. T. AU - Karthaus, M. AU - Riess, H. AU - Lipp, H. P. AU - Hauschild, A. PY - 2011 DA - 2011// TI - Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq387 DO - 10.1093/annonc/mdq387 ID - Potthoff2011 ER - TY - JOUR AU - Fisher, B. AU - Dignam, J. AU - Bryant, J. AU - DeCillis, A. AU - Wickerham, D. L. AU - Wolmark, N. AU - Costantino, J. AU - Redmond, C. AU - Fisher, E. R. AU - Bowman, D. M. PY - 1996 DA - 1996// TI - Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors JO - J Natl Cancer Inst VL - 88 UR - https://doi.org/10.1093/jnci/88.21.1529 DO - 10.1093/jnci/88.21.1529 ID - Fisher1996 ER - TY - JOUR AU - Loprinzi, C. L. AU - Zahasky, K. M. AU - Sloan, J. A. AU - Novotny, P. J. AU - Quella, S. K. PY - 2000 DA - 2000// TI - Tamoxifen-induced hot flashes JO - Clin Breast Cancer VL - 1 UR - https://doi.org/10.3816/CBC.2000.n.004 DO - 10.3816/CBC.2000.n.004 ID - Loprinzi2000 ER - TY - JOUR AU - Love, R. R. AU - Feyzi, J. M. PY - 1993 DA - 1993// TI - Reduction in vasomotor symptoms from tamoxifen over time JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.8.673-a DO - 10.1093/jnci/85.8.673-a ID - Love1993 ER - TY - JOUR AU - Mortimer, J. E. AU - Flatt, S. W. AU - Parker, B. A. AU - Gold, E. B. AU - Wasserman, L. AU - Natarajan, L. AU - Pierce, J. P. PY - 2008 DA - 2008// TI - Tamoxifen, hot flashes and recurrence in breast cancer JO - Breast Cancer Res Treat VL - 108 UR - https://doi.org/10.1007/s10549-007-9612-x DO - 10.1007/s10549-007-9612-x ID - Mortimer2008 ER - TY - JOUR AU - Cuzick, J. AU - Sestak, I. AU - Cella, D. AU - Fallowfield, L. PY - 2008 DA - 2008// TI - Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70259-6 DO - 10.1016/S1470-2045(08)70259-6 ID - Cuzick2008 ER - TY - JOUR AU - Boekhout, A. H. AU - Vincent, A. D. AU - Dalesio, O. B. AU - van den Bosch, J. AU - Foekema-Töns, J. H. AU - Adriaansz, S. AU - Sprangers, S. AU - Nuijen, B. AU - Beijnen, J. H. AU - Schellens, J. H. M. PY - 2011 DA - 2011// TI - Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.1298 DO - 10.1200/JCO.2010.33.1298 ID - Boekhout2011 ER - TY - JOUR AU - Sloan, J. A. AU - Loprinzi, C. L. AU - Novotny, P. J. AU - Barton, D. L. AU - Lavasseur, B. I. AU - Windschitl, H. PY - 2001 DA - 2001// TI - Methodologic lessons learned from hot flash studies JO - J Clin Oncol VL - 19 ID - Sloan2001 ER - TY - STD TI - Wet Medisch-wetenschappelijk Onderzoek met mensen - (Dutch Act on medical research involving human beings, February 26, 1998). [http://wetten.overheid.nl/BWBR0009408] UR - http://wetten.overheid.nl/BWBR0009408 ID - ref23 ER - TY - JOUR AU - Teunissen, S. F. AU - Jager, N. G. L. AU - Rosing, H. AU - Schinkel, A. H. AU - Schellens, J. H. M. AU - Beijnen, J. H. PY - 2011 DA - 2011// TI - Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry JO - J Chromatogr B Analyt Technol Biomed Life Sci VL - 879 UR - https://doi.org/10.1016/j.jchromb.2011.04.011 DO - 10.1016/j.jchromb.2011.04.011 ID - Teunissen2011 ER - TY - BOOK PY - 2011 DA - 2011// TI - Guideline on bioanalytical method validation PB - EMEA CY - London(UK) ID - ref25 ER - TY - BOOK PY - 2001 DA - 2001// TI - Bioanalytical Method Validation PB - FDA CY - Rockville, MD (USA) ID - ref26 ER - TY - JOUR AU - Lammers, L. A. AU - Mathijssen, R. H. J. AU - van Gelder, T. AU - Bijl, M. J. AU - de Graan, A. -. J. M. AU - Seynaeve, C. AU - van Fessem, M. A. AU - Berns, E. M. AU - Vulto, A. G. AU - van Schaik, R. H. N. PY - 2010 DA - 2010// TI - The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer JO - Br J Cancer VL - 103 UR - https://doi.org/10.1038/sj.bjc.6605800 DO - 10.1038/sj.bjc.6605800 ID - Lammers2010 ER - TY - JOUR AU - Lorizio, W. AU - Wu, A. H. B. AU - Beattie, M. S. AU - Rugo, H. AU - Tchu, S. AU - Kerlikowske, K. AU - Ziv, E. PY - 2012 DA - 2012// TI - Clinical and biomarker predictors of side effects from tamoxifen JO - Breast Cancer Res Treat VL - 132 UR - https://doi.org/10.1007/s10549-011-1893-4 DO - 10.1007/s10549-011-1893-4 ID - Lorizio2012 ER - TY - JOUR AU - Sestak, I. AU - Kealy, R. AU - Edwards, R. AU - Forbes, J. AU - Cuzick, J. PY - 2006 DA - 2006// TI - Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.3745 DO - 10.1200/JCO.2005.04.3745 ID - Sestak2006 ER - TY - JOUR AU - Goetz, M. P. AU - Rae, J. M. AU - Suman, V. J. AU - Safgren, S. L. AU - Ames, M. M. AU - Visscher, D. W. AU - Reynolds, C. AU - Couch, F. J. AU - Lingle, W. L. AU - Flockhart, D. A. PY - 2005 DA - 2005// TI - Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.03.3266 DO - 10.1200/JCO.2005.03.3266 ID - Goetz2005 ER - TY - JOUR AU - Erlik, Y. AU - Meldrum, D. R. AU - Judd, H. L. PY - 1982 DA - 1982// TI - Estrogen levels in postmenopausal women with hot flashes JO - Obstet Gynecol VL - 59 ID - Erlik1982 ER - TY - JOUR AU - Guthrie, J. R. AU - Dennerstein, L. AU - Hopper, J. L. AU - Burger, H. G. PY - 1996 DA - 1996// TI - Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women JO - Obstet Gynecol VL - 88 UR - https://doi.org/10.1016/0029-7844(96)00196-2 DO - 10.1016/0029-7844(96)00196-2 ID - Guthrie1996 ER - TY - JOUR AU - Kronenberg, F. PY - 2010 DA - 2010// TI - Menopausal hot flashes: a review of physiology and biosociocultural perspective on methods of assessment JO - J Nutr VL - 140 UR - https://doi.org/10.3945/jn.109.120840 DO - 10.3945/jn.109.120840 ID - Kronenberg2010 ER - TY - JOUR AU - Visvanathan, K. AU - Gallicchio, L. AU - Schilling, C. AU - Babus, J. K. AU - Lewis, L. M. AU - Miller, S. R. AU - Zacur, H. AU - Flaws, J. A. PY - 2005 DA - 2005// TI - Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women JO - Obstet Gynecol VL - 106 UR - https://doi.org/10.1097/01.AOG.0000187308.67021.98 DO - 10.1097/01.AOG.0000187308.67021.98 ID - Visvanathan2005 ER - TY - JOUR AU - Moilanen, J. AU - Aalto, A. M. AU - Hemminki, E. AU - Aro, A. R. AU - Raitanen, J. AU - Luoto, R. PY - 2010 DA - 2010// TI - Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women JO - Maturitas VL - 67 UR - https://doi.org/10.1016/j.maturitas.2010.08.007 DO - 10.1016/j.maturitas.2010.08.007 ID - Moilanen2010 ER - TY - JOUR AU - Freeman, E. W. AU - Sammel, M. D. AU - Lin, H. AU - Liu, Z. AU - Gracia, C. R. PY - 2011 DA - 2011// TI - Duration of menopausal hot flushes and associated risk factors JO - Obstetrics & Gynecology VL - 117 UR - https://doi.org/10.1097/AOG.0b013e318214f0de DO - 10.1097/AOG.0b013e318214f0de ID - Freeman2011 ER - TY - JOUR AU - Thurston, R. C. AU - Santoro, N. AU - Matthews, K. A. PY - 2011 DA - 2011// TI - Adiposity and hot flashes in midlife women: a modifying role of age JO - J Clin Endocrinol Metab VL - 96 UR - https://doi.org/10.1210/jc.2011-1082 DO - 10.1210/jc.2011-1082 ID - Thurston2011 ER - TY - JOUR AU - Gjelsvik, B. AU - Rosvold, E. O. AU - Straand, J. AU - Dalen, I. AU - Hunskaar, S. PY - 2011 DA - 2011// TI - Symptom prevalence during menopause and factors associated with symptoms and menopausal age. Results from the Norwegian Hordaland Women’s Cohort study JO - Maturitas VL - 70 UR - https://doi.org/10.1016/j.maturitas.2011.09.011 DO - 10.1016/j.maturitas.2011.09.011 ID - Gjelsvik2011 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/13/612/prepub UR - http://www.biomedcentral.com/1471-2407/13/612/prepub ID - ref39 ER -